Thoracoscopic surgery for recurrent tracheoesophageal fistula after esophageal atresia repair.


Journal

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
ISSN: 1442-2050
Titre abrégé: Dis Esophagus
Pays: United States
ID NLM: 8809160

Informations de publication

Date de publication:
04 Sep 2020
Historique:
received: 08 02 2020
revised: 08 03 2020
accepted: 31 03 2020
pubmed: 24 4 2020
medline: 29 7 2021
entrez: 24 4 2020
Statut: ppublish

Résumé

We aimed to investigate the safety, feasibility, and outcomes of thoracoscopic surgery for recurrent tracheoesophageal fistula (rTEF) after esophageal atresia repair. The medical records and follow-up data of 31 patients who underwent thoracoscopic surgery for rTEF at a single institution were collected and reviewed. In total, 31 patients were enrolled with a median age of 7 months (range: 3-30 months) and a median weight of 6,000 g (range: 4,000-12,000 g) before reoperation. The median operation time for the entire series was 2.9 hours (range: 1.5-7.5 hours), and the median total hospitalization duration after surgery was 19 days (range: 11-104 days). One patient died of anastomotic leakage, a second rTEF, severe malnutrition, and thoracic infection; the mortality rate was 3.23% (1/31). Nine patients (9/31, 29.03%) had an uneventful recovery, and the incidences of postoperative anastomotic leakage, anastomotic stricture, and second rTEF were 25.81%, 61.29%, and 9.68%, respectively. After a median follow-up of 12 months (range: 3-24 months), 26 survivors resumed full oral feeding, 2 were tube fed, 2 required a combination of methods, and 4 patients experienced severe respiratory complications. In total, 9 patients had pathological gastroesophageal reflux, and 2 patients eventually underwent Nissen fundoplication. Of the 30 survivors with growth chart data, the median weight for age Z-score, height for age Z-score, and weight for height Z-score were - 0.46 (range: -5.1 to 2.8), 0.75 (range: -2.7 to 4.7), and - 1.14 (range: -6.8 to 3.0), respectively. Thoracoscopic surgical repair for rTEF is safe, feasible, and effective with acceptable mortality and morbidity.

Identifiants

pubmed: 32322874
pii: 5823895
doi: 10.1093/dote/doaa023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of International Society for Diseases of the Esophagus. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Kaiyun Hua (K)

Department of Neonatal Surgery, Beijing Children Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Shen Yang (S)

Department of Neonatal Surgery, Beijing Children Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Yanan Zhang (Y)

Department of Neonatal Surgery, Beijing Children Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Yong Zhao (Y)

Department of Neonatal Surgery, Beijing Children Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Yichao Gu (Y)

Department of Neonatal Surgery, Beijing Children Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Shuangshuang Li (S)

Department of Neonatal Surgery, Beijing Children Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Junmin Liao (J)

Department of Neonatal Surgery, Beijing Children Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Jinshi Huang (J)

Department of Neonatal Surgery, Beijing Children Hospital, Capital Medical University, National Center for Children's Health, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH